Publication | Closed Access

Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group

Autoimmune DiseaseMedicineImmunologyClinical DermatologyEuropean NetworkMulticenter European StudyDermatologyImmunotherapyPsoriatic ArthritisImmune Checkpoint-mediated Psoriasis